Recalls / Active ingredient / Doxorubicin Hydrochloride
Doxorubicin Hydrochloride
3 FDA drug recalls involving the active ingredient “Doxorubicin Hydrochloride”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2023-08-24 | Class II | Doxil (doxorubicin hydrochloride liposome injection) 50 mg in 25 mL (2 mg/mL), Single-Dose Vial, Rx only, Manu | Baxter Healthcare Corporation |
| 2020-11-17 | Class III | DOXOrubicin Hydrochloride Injection, USP, 10 mg / 5 mL (2 mg / mL), 5 mL fill in a 6 mL vial, Single Dose Vial | Fresenius Kabi USA, LLC |
| 2018-01-16 | Class II | DOXOrubicin Hydrochloride Liposome Injection, 20 mg/10 ml (2 mg/mL), 10 mL Single Use Vial, Distributed by: Su | Sun Pharmaceutical Industries, Inc. |